Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Naloxone nasal spray - Adapt Pharma/Opiant Pharmaceuticals

Next Previous
X
Search
Drug Profile

Naloxone nasal spray - Adapt Pharma/Opiant Pharmaceuticals

Alternative Names: LT-12; LT-20; LT-21; LT-22; Naloxon B; Naloxone HCl; NARCAN Nasal Spray; Narcan Nasal Spray; OPNT 001

Latest Information Update: 09 Mar 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Lightlake Therapeutics
  • Developer Adapt Pharma; National Institute of Drug Abuse; Opiant Pharmaceuticals; University of Pennsylvania
  • Class Antidotes; Behavioural disorder therapies; Benzofurans; Drug withdrawal therapies; Isoquinolines; Ketones; Laxatives; Morphinans; Small molecules
  • Mechanism of Action Opioid mu receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Opioid-related disorders
  • Phase II Eating disorders
  • No development reported Cocaine-related disorders; Substance-related disorders
  • Discontinued Bulimia nervosa

Most Recent Events

  • 02 Mar 2023 Opiant Pharmaceuticals has been acquired by Indivior
  • 17 Mar 2022 Opiant Pharmaceuticals has patent protection for naloxone nasal spray in Mexico and Spain
  • 31 Dec 2021 Launched for Opioid-related disorders in Europe (Intranasal)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top